Elite Pharmaceuticals (ELTP) Shares Outstanding (Diluted) (2010 - 2026)
Elite Pharmaceuticals (ELTP) posted Shares Outstanding (Diluted) of 1.13 billion for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 5.6% from 1.07 billion a year earlier but down 0.9% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals' Shares Outstanding (Diluted) came in at 1.14 billion, up 6.6% from FY2025.
- Annual Shares Outstanding (Diluted) has increased for five consecutive fiscal years, with a five-year compound annual growth rate of 3.8% (FY2021 to FY2026).
- In prior fiscal years, Elite Pharmaceuticals' Shares Outstanding (Diluted) was 1.07 billion in FY2025 (+4.4%), 1.02 billion in FY2024 (+1.0%), 1.01 billion in FY2023 (+0.2%) and 1.01 billion in FY2022 (+7.2%).
- Quarterly Shares Outstanding (Diluted) has run from a low of 1.01 billion in fiscal Q4 2022 to a high of 1.14 billion in fiscal Q2 2026 over five years.
- On a year-over-year basis, Shares Outstanding (Diluted) has increased in each of the last four quarters, with growth averaging 4.8% over the last eight quarters.
- The strongest year-over-year quarter for Shares Outstanding (Diluted) in the past five years was fiscal Q2 2022, with growth of 10.7%; the weakest was fiscal Q1 2026, with a decline of 0.7%.
- According to Business Quant data, Shares Outstanding (Diluted) for the three prior fiscal quarters was 1.14 billion (Q4 2026), 1.14 billion (Q3 2026) and 1.14 billion (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Elite Pharmaceuticals | 269.31 Mn | 150.98 Mn | 13.51 Mn | 1.13 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.13 Bn |
| Mar 31, 2026 | 1.14 Bn |
| Dec 31, 2025 | 1.14 Bn |
| Sep 30, 2025 | 1.14 Bn |
| Jun 30, 2025 | 1.07 Bn |
| Mar 31, 2025 | 1.07 Bn |
| Dec 31, 2024 | 1.07 Bn |
| Sep 30, 2024 | 1.07 Bn |
| Jun 30, 2024 | 1.08 Bn |
| Mar 31, 2024 | 1.02 Bn |
| Dec 31, 2023 | 1.02 Bn |
| Sep 30, 2023 | 1.02 Bn |
| Jun 30, 2023 | 1.01 Bn |
| Mar 31, 2023 | 1.01 Bn |
| Dec 31, 2022 | 1.01 Bn |
| Sep 30, 2022 | 1.01 Bn |
| Jun 30, 2022 | 1.01 Bn |
| Mar 31, 2022 | 1.01 Bn |
| Dec 31, 2021 | 1.01 Bn |
| Sep 30, 2021 | 1.01 Bn |
API Access
Elite Pharmaceuticals Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();